News headlines about Blackrock Health Sciences Trust (NYSE:BME) have been trending positive on Thursday, Accern reports. Accern scores the sentiment of press coverage by monitoring more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Blackrock Health Sciences Trust earned a media sentiment score of 0.39 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 45.3345190217191 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
BME traded up $0.06 during trading on Thursday, reaching $34.75. The company’s stock had a trading volume of 22,408 shares, compared to its average volume of 41,945. Blackrock Health Sciences Trust has a 1 year low of $32.81 and a 1 year high of $38.00.
The firm also recently announced a monthly dividend, which will be paid on Monday, April 30th. Shareholders of record on Monday, April 16th will be paid a $0.20 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 6.91%. The ex-dividend date is Friday, April 13th.
COPYRIGHT VIOLATION NOTICE: “Blackrock Health Sciences Trust (NYSE:BME) Receiving Favorable News Coverage, Study Shows” was reported by BBNS and is owned by of BBNS. If you are viewing this piece of content on another publication, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be read at https://baseballnewssource.com/2018/04/05/blackrock-health-sciences-trust-bme-receives-news-impact-score-of-0-39/2027749.html.
BlackRock Health Sciences Trust is a non-diversified, closed-end management investment company (the Trust). The Trust’s investment objective is to provide total return through a combination of current income, current gains and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its assets in equity securities of companies engaged in the health sciences and related industries and equity derivatives with exposure to the health sciences industry.
Receive News & Ratings for Blackrock Health Sciences Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Blackrock Health Sciences Trust and related companies with MarketBeat.com's FREE daily email newsletter.